Delayed toxicities after CAR T cell therapy for multiple myeloma are connected and potentially preventable

ORLANDO – Serious side effects, including neurotoxicity and intestinal inflammation, that appear weeks or months after patients receive CAR T cell therapy for multiple myeloma share a common immune root…